Reports

Resources on biosimilar medicines

Menu

12

Meitheamh 2025

0

Budgetary impact analysis of biosimilar medicines in the NHS (2020-2030)

12 June 2025 BioSim (EN) Biosim

24

Apr 2025

0

Biosimilars in Primary Care

Apr 24 2025 BioSim (EN) Biosim

27

Márta 2025

0

Patients and biosimilars: vision and expectations

March 27 2025 BioSim (EN) Biosim

18

Meitheamh 2024

0

Proposal for the Creation of the National Observatory of Biosimilar Medicines

18 June 2024 BioSim (EN) Biosim

27

February 2024

0

Study on the market for biosimilar medicines in the National Health System in Spain

Feb 27 2024 BioSim (EN) Biosim

02

Deireadh Fómhair 2023

0

Report on savings on generic and biosimilar drugs in the US.

October 02 2023 Other entities Biosim

28

Meitheamh 2023

0

“Early Treatment”: The role of biosimilars

28 June 2023 BioSim (EN) Biosim

15

May 2023

0

EMA Annual Report 2022

15 May 2023 Other entities Biosim

04

December 2022

0

Monograph "Real world evidence: Abstract library"

04 2022 December Other entities Biosim

10

November 2022

0

Biosimilars: innovation from sustainability

November 10 2022 BioSim (EN) Biosim

04

Deireadh Fómhair 2022

0

Trends in the field of biosimilars in the United States

October 04 2022 Other entities Biosim

04

Sep 2022

0

Analysis of US Health Savings from Generics and Biosimilars in 2021

04 September 2022 Other entities Biosim

24

February 2022

0

Biosimilars in the new National Health System: Proposals for action

Feb 24 2022 BioSim (EN) Biosim

24

February 2022

0

Biosimilars within the new Spanish National Health System. Proposals for action

Feb 24 2022 BioSim Biosim

30

November 2021

0

Public procurement of biosimilar medicines in the National Health System

November 30 2021 BioSim (EN) Biosim

15

November 2021

0

Improving Understanding and Acceptance of Biosimilars in the United States

November 15 2021 Other entities Biosim

03

November 2021

0

Biosimilars in the treatment of solid tumors

November 03 2021 Other entities Biosim

19

Deireadh Fómhair 2021

0

The US Generic & Biosimilar Medicines Savings Report

October 19 2021 Other entities Biosim

01

Christmas

0

Biennial Report of BioSim Activities 2019-2020

Jul 01 2021 BioSim (EN) Biosim

24

Márta 2021

0

Basis for a biosimilar gainsharing project

March 24 2021 BioSim (EN) Biosim

05

Jan 2021

0

Education in Biosimilars - Whitepaper

Jan 05 2021 Other entities Biosim

27

November 2020

0

Clinical management, incentives and biosimilars

November 27 2020 BioSim (EN) Biosim

27

November 2020

0

Budget impact analysis of biosimilar medicines in the Spanish National Health System (2009-2022)

November 27 2020 BioSim (EN) Biosim

18

November 2020

0

What do we know about biosimilar biologics?

November 18 2020 Other entities Biosim

18

November 2020

0

Communication in biosimilar biologics

November 18 2020 Other entities Biosim

17

November 2020

0

Variability in the adoption of biosimilars

November 17 2020 Other entities Biosim

15

Deireadh Fómhair 2020

0

Hospital expenditure of the National Health System: pharmacy and investment in capital goods

October 15 2020 Other entities Biosim

14

Deireadh Fómhair 2020

0

Biosimilars in the United States 2020–2024 COMPETITION, SAVINGS, AND SUSTAINABILITY

October 14 2020 Other entities Biosim

07

Deireadh Fómhair 2020

0

Biosimilars, for value-based healthcare

October 07 2020 Other entities Biosim

29

Meitheamh 2020

0

Country Scorecards for Biosimilar Sustainability

29 June 2020 Other entities Biosim

02

Deireadh Fómhair 2019

0

Biosimilars in the European Union

October 02 2019 Other entities Biosim

01

May 2019

0

The principle of justice and biosimilar medicines in the National Health System (SNS)

01 May 2019 BioSim (EN) Biosim

12

Christmas

0

Biosimilars Action Plan: Balancing Innovation and Competition

Jul 12 2018 Other entities Biosim

19

Christmas

0

Biosimilars: new ways to innovate

Jul 19 2017 BioSim (EN) Biosim

01

Christmas

0

What do I need to know about Biosimilar Medicines. Information for patients.

Jul 01 2016 Other entities Biosim

14

Christmas

0

What you should know about biosimilar medicines. European Commission Consensus Report

Jul 14 2013 Other entities Biosim

    BioSim Newsletter

    Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.

    PRIVACY POLICY

    SUBSCRIBE